Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending Jan 12, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending Jan 12, 2025

by Jonathan Hodson-Walker | Jan 15, 2025 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Verdiva Bio: The company raised $410 million of Series A venture funding in a deal led by General Atlantic and Forbion on January 9, 2025. Lilly Asia Ventures, OrbiMed, LYFE Capital, RA...
Healthcare Private Placement and M&A Transactions Review Week Ending Jan 5, 2025

Healthcare Private Placement and M&A Transactions Review Week Ending Jan 5, 2025

by Jonathan Hodson-Walker | Jan 8, 2025 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Alzheon: The company raised $125 million of Series E venture funding in a deal led by Alerce Medical Technology Partners on January 2, 2025. The company is a developer of a small...
Healthcare Private Placement and M&A Transactions Review Week Ending December 29, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending December 29, 2024

by Jonathan Hodson-Walker | Jan 3, 2025 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Borealis Biosciences: The company raised $180 million of Series A venture funding in a deal led by Novartis and Westlake Village BioPartners on December 19, 2024. Versant Ventures and other...
Healthcare Private Placement and M&A Transactions Review Week Ending December 15, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending December 15, 2024

by Jonathan Hodson-Walker | Dec 18, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Angitia Biopharmaceuticals: The company raised $120 million of Series C venture funding in a deal led by Bain Capital Life Sciences on December 11, 2024. Yonghua Capital, 3H Health...
Healthcare Private Placement and M&A Transactions Review Week Ending December 8, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending December 8, 2024

by Jonathan Hodson-Walker | Dec 11, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Nuvig Therapeutics: The company raised $161 million of Series B venture funding in a deal led by Sanofi Ventures on December 5, 2024. Abrdn, Novo Holdings, Leaps by Bayer, Norwest Venture...
Healthcare Private Placement and M&A Transactions Review Week Ending December 1, 2024

Healthcare Private Placement and M&A Transactions Review Week Ending December 1, 2024

by Jonathan Hodson-Walker | Dec 5, 2024 | Healthcare

Strategy | Financing Transactions Private Placement / Financing Transactions Scan.com: The company raised GBP 59.2 million of venture funding through a combination of debt and equity on November 28, 2024. GBP 38.2 million of Series C was from undisclosed investors....
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending May 25, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 25, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending May 25, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending May 18, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending May 18, 2025

Categories

Archives